Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
CA 2210875 C · Owner: Amgen Inc. · Inventors: Goldenberg, Merrill S.; Beekman, Alice C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to an improved method for the cytoplasmic delivery of oligonucleotides using cationic copolymers based on vinyl alcohol with low levels of vinyl amine (PVAVAMs). Improved composition for use in such method are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 11, 1996 and granted May 1, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 11, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 11, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.